(Q33395662)

26 July 2017

1 reference

title

Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli (English)

1 reference

26 July 2017

1 reference

Kiyotaka Nishikawa

1

1 reference

26 July 2017

publication date

5 June 2011

1 reference

Archivum Immunologiae et Therapiae Experimentalis

26 July 2017

published in

1 reference

26 July 2017

volume

59

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

239-247

1 reference

Investigation of Shiga-like Toxin Binding to Chemically Synthesized Oligosaccharide Sequences

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Shiga toxin-producing Escherichia coli: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

In vivo supramolecular templating enhances the activity of multivalent ligands: a potential therapeutic against the Escherichia coli O157 AB5 toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage H30 shiga-like toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

A peptide library approach identifies a specific inhibitor for the ZAP-70 protein tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Designer probiotics for prevention of enteric infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Inhibition of retrograde transport protects mice from lethal ricin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages fromEscherichia coli933

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0130-5

10.1007/S00005-011-0130-5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1031652412

0 references

1 reference